• For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress
    Jul 15 2025

    Dr Rahul Aggarwal and Dr William K Oh and nurse practitioners Ms Monica Averia and Ms Kathleen D Burns discuss the current treatment landscape for prostate cancer and protocols to mitigate and manage treatment-emergent adverse events.

    NCPD information and select publications here.

    Show More Show Less
    1 hr and 28 mins
  • Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
    Jul 11 2025

    Dr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Prof Andrea Necchi from the IRCCS San Raffaele Hospital in Milan, Italy, and Prof Thomas Powles from the Barts Cancer Institute in London provide their perspectives on clinical scenarios and datasets informing the care of patients with urothelial bladder cancer.

    CME information and select publications here.

    Show More Show Less
    1 hr
  • Prostate Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
    Jun 26 2025

    Dr Neeraj Agarwal from the University of Utah Huntsman Cancer Institute in Salt Lake City, Dr Andrew J Armstrong from Duke Cancer Institute in Durham, North Carolina, Dr Himisha Beltran from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Fred Saad from the University of Montreal Hospital Center in Québec, Canada, and Dr Rana R McKay from the UC San Diego Moores Cancer Center discuss recent updates on available and novel treatment strategies for prostate cancer.

    CME information and select publications here.

    Show More Show Less
    1 hr and 56 mins
  • Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting
    Jun 3 2025

    Dr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer.

    CME information and select publications here.

    Show More Show Less
    1 hr and 23 mins
  • Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
    May 22 2025

    Clinical investigators discuss available data guiding the management of urothelial bladder cancer. 

    CME information and select publications here.

    Show More Show Less
    49 mins
  • Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
    May 15 2025

    Dr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients.

    CME information and select publications here.

    Show More Show Less
    1 hr
  • Prostate Cancer — Fourth Annual National General Medical Oncology Summit
    Apr 29 2025

    Clinical investigators discuss available data guiding the management of prostate cancers. 

    CME information and select publications here.

    Show More Show Less
    48 mins
  • Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates
    Apr 23 2025

    Dr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers.

    CME information and select publications here.

    Show More Show Less
    44 mins